⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Coultreon Biopharma Appoints Nate Massari as Chief Business Officer
globenewswire.com
JNJ
AZN
CCRN
Anti-GPC3 Targeted Therapies Market Poised for Growth Through 2040 as Expanding Patient Populations and Competitive Innovation Unlock New Opportunities
globenewswire.com
AZN
BCRX
Drug Discovery Technologies Market - Global Forecast 2026-2032
globenewswire.com
ABT
AMGN
AZN
BIO
BMY
GEHC
GILD
ILMN
IQV
MRK
NVS
PFE
SNY
TMO
TAGRISSO ® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial
businesswire.com
AZN
Enhertu ® Demonstrated a Median Progression-Free Survival of 14.3 Months as First-Line Therapy in Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 Trial
businesswire.com
AZN
Canada ICT Market (2026-2031) - Growth Driven by Accelerating Digital Transformation
globenewswire.com
MSFT
AMZN
CSCO
GOOG
IBM
ORCL
CRM
SHOP
LSPD
NOW
PANW
ZS
FTNT
CDNS
SNPS
AMD
NVDA
INTC
MU
AMAT
LRCX
KLAC
TEL
NXPI
ON
ADI
TXN
AEHR
TER
PLTR
AI
SMCI
DELL
HPQ
STX
WDC
REGN
GILD
BIIB
CRSP
XOM
CVX
NEE
DUK
SO
PCG
ETSY
PYPL
QCOM
MRVL
ADSK
CDW
ACN
CSGS
NTAP
VRTX
MRNA
BMY
AMGN
AZN
PFE
JNJ
GOOGL
AAPL
META
NFLX
TSLA
GE
BA
RTX
LMT
GD
HON
CAT
DE
ROKU
WIX
RCL
CCL
NCLH
ATOS
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight
globenewswire.com
NVS
ALLO
LEGN
CBIO
MBIO
CRSP
INCY
IMPP
SANA
VOR
CARG
AUTL
ARCL
LYEL
PRE
BEAM
CART
TAK
AZN
MRK
BMY
GEN
DGX
GMAB
ABBV
RLGT
CRGO
JNJ
GILD
JAZZ
SYBX
CASI
ATRA
SHEN
BIIB
VREX
The Galien Foundation Announces Nominees for the Inaugural 2026 Prix Galien Patient First Award in Honor of Michael J. Fox
prnewswire.com
AGIO
AZN
AMGN
ARDX
BDX
BMY
CGON
FERG
GILD
JNJ
UTHR
MRK
NVS
PFE
PRM
IQV
URGN
Graph AI Raises $13.3M Series A to Scale the First AI-Native Operating System for Patient Safety
prnewswire.com
NVDA
GOOG
MSFT
AMZN
META
IBM
ORCL
CRM
ADBE
INTC
AMD
QCOM
AMAT
MU
SMCI
ASML
LRCX
KLAC
TER
SNPS
CDNS
PANW
CRWD
DDOG
PLTR
SNOW
AI
UPST
SOFI
COIN
RIOT
MARA
PLUG
FCEL
ROKU
NFLX
DIS
CMCSA
TCOM
BABA
JD
PDD
NIO
LI
TSLA
RIVN
LCID
GM
F
STLA
VWAGY
HON
GE
BA
LMT
RTX
GD
NOC
AVAV
KBR
BWXT
XOM
CVX
SHEL
BIDU
NET
FTNT
CSCO
HPQ
DELL
LEN
DHI
NVR
PHM
TMHC
MTH
KBH
BKH
ESNT
MTG
WFG
RGA
AGNC
TWO
PSEC
ARCC
BX
KKR
APO
CME
ICE
MSCI
SPGI
EQIX
AMKR
WDC
SE
MELI
AMGN
GILD
BMY
PFE
MRK
LLY
ABBV
REGN
VRTX
BIIB
AZN
SNY
NVS
ROG
TEVA
BHC
ALKS
IRTC
EXAS
CRIS
EDIT
NTLA
BNTX
MRNA
ALNY
BTAI
NVO
LULU
SIRI
SPOT
PTON
GOOGL
ZS
XPEV
Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs
businesswire.com
ESPR
AZN